CN103690393A - Skin-whitening anti-wrinkle biological silk mask - Google Patents
Skin-whitening anti-wrinkle biological silk mask Download PDFInfo
- Publication number
- CN103690393A CN103690393A CN201310744465.3A CN201310744465A CN103690393A CN 103690393 A CN103690393 A CN 103690393A CN 201310744465 A CN201310744465 A CN 201310744465A CN 103690393 A CN103690393 A CN 103690393A
- Authority
- CN
- China
- Prior art keywords
- skin
- grams
- gram
- wrinkle
- whitening anti
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000001153 anti-wrinkle effect Effects 0.000 title abstract 5
- 102000007625 Hirudins Human genes 0.000 claims abstract description 22
- 108010007267 Hirudins Proteins 0.000 claims abstract description 22
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 claims abstract description 22
- 229940006607 hirudin Drugs 0.000 claims abstract description 22
- 235000018102 proteins Nutrition 0.000 claims abstract description 19
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 19
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 19
- 102000000588 Interleukin-2 Human genes 0.000 claims abstract description 17
- 108010002350 Interleukin-2 Proteins 0.000 claims abstract description 17
- 150000001413 amino acids Chemical class 0.000 claims abstract description 17
- 230000002087 whitening effect Effects 0.000 claims abstract description 15
- 210000002826 placenta Anatomy 0.000 claims abstract description 14
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 14
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 12
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 12
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 102000014171 Milk Proteins Human genes 0.000 claims abstract description 9
- 108010011756 Milk Proteins Proteins 0.000 claims abstract description 9
- 235000021239 milk protein Nutrition 0.000 claims abstract description 9
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 7
- 210000002374 sebum Anatomy 0.000 claims abstract description 7
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 7
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 7
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 235000001014 amino acid Nutrition 0.000 claims description 15
- 241000283898 Ovis Species 0.000 claims description 13
- 239000003906 humectant Substances 0.000 claims description 6
- 210000004698 lymphocyte Anatomy 0.000 claims description 4
- 239000000243 solution Substances 0.000 claims description 4
- 101800003838 Epidermal growth factor Proteins 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 229940116977 epidermal growth factor Drugs 0.000 claims description 3
- 238000005457 optimization Methods 0.000 claims description 3
- 239000011550 stock solution Substances 0.000 claims description 3
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims description 3
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 16
- 239000008280 blood Substances 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 12
- 230000003750 conditioning effect Effects 0.000 abstract description 7
- 230000004089 microcirculation Effects 0.000 abstract description 6
- 230000037303 wrinkles Effects 0.000 abstract description 5
- 241001494479 Pecora Species 0.000 abstract description 4
- 230000007969 cellular immunity Effects 0.000 abstract description 4
- 230000003020 moisturizing effect Effects 0.000 abstract description 4
- 230000001815 facial effect Effects 0.000 abstract description 3
- 230000032683 aging Effects 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 230000003301 hydrolyzing effect Effects 0.000 abstract 2
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical group CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 abstract 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Natural products CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 208000030961 allergic reaction Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000001143 conditioned effect Effects 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 231100000956 nontoxicity Toxicity 0.000 abstract 1
- 230000037072 sun protection Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 27
- 239000002537 cosmetic Substances 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 5
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 108090000190 Thrombin Proteins 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 229960004072 thrombin Drugs 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102400001368 Epidermal growth factor Human genes 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000003169 placental effect Effects 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000002537 thrombolytic effect Effects 0.000 description 2
- 102000005606 Activins Human genes 0.000 description 1
- 108010059616 Activins Proteins 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 241000237903 Hirudo Species 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000488 activin Substances 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 210000003725 endotheliocyte Anatomy 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229940044627 gamma-interferon Drugs 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004719 natural immunity Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310744465.3A CN103690393B (en) | 2013-12-30 | 2013-12-30 | Skin-whitening anti-wrinkle biological silk mask |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310744465.3A CN103690393B (en) | 2013-12-30 | 2013-12-30 | Skin-whitening anti-wrinkle biological silk mask |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103690393A true CN103690393A (en) | 2014-04-02 |
CN103690393B CN103690393B (en) | 2016-07-13 |
Family
ID=50352169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310744465.3A Expired - Fee Related CN103690393B (en) | 2013-12-30 | 2013-12-30 | Skin-whitening anti-wrinkle biological silk mask |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103690393B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106511227A (en) * | 2016-11-25 | 2017-03-22 | 江苏爱西施科技服务咨询股份有限公司 | Skincare facial mask containing silk peptide and preparation method of skincare facial mask |
CN107510619A (en) * | 2017-09-06 | 2017-12-26 | 深圳肽之妃科技有限公司 | A kind of complex polypeptide facial mask and preparation method thereof |
CN107519037A (en) * | 2017-09-06 | 2017-12-29 | 深圳肽之妃科技有限公司 | A kind of liquid facial mask containing polypeptide and preparation method thereof and application method |
CN109260046A (en) * | 2018-09-28 | 2019-01-25 | 重庆雅素生物科技有限公司 | Hirudin repairs application, composition and the preparation method of skin red capillary or hormone face |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1522689A (en) * | 2003-09-12 | 2004-08-25 | 周维海 | Leech extract cosmetics and method for making same |
CN102307561A (en) * | 2008-06-30 | 2012-01-04 | 奥夫莱夫塔埃克尼公司 | Use of plant-derived recombinant growth factors in skin care |
-
2013
- 2013-12-30 CN CN201310744465.3A patent/CN103690393B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1522689A (en) * | 2003-09-12 | 2004-08-25 | 周维海 | Leech extract cosmetics and method for making same |
CN102307561A (en) * | 2008-06-30 | 2012-01-04 | 奥夫莱夫塔埃克尼公司 | Use of plant-derived recombinant growth factors in skin care |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106511227A (en) * | 2016-11-25 | 2017-03-22 | 江苏爱西施科技服务咨询股份有限公司 | Skincare facial mask containing silk peptide and preparation method of skincare facial mask |
CN107510619A (en) * | 2017-09-06 | 2017-12-26 | 深圳肽之妃科技有限公司 | A kind of complex polypeptide facial mask and preparation method thereof |
CN107519037A (en) * | 2017-09-06 | 2017-12-29 | 深圳肽之妃科技有限公司 | A kind of liquid facial mask containing polypeptide and preparation method thereof and application method |
CN107510619B (en) * | 2017-09-06 | 2020-11-24 | 深圳肽之妃科技有限公司 | Composite polypeptide mask and preparation method thereof |
CN109260046A (en) * | 2018-09-28 | 2019-01-25 | 重庆雅素生物科技有限公司 | Hirudin repairs application, composition and the preparation method of skin red capillary or hormone face |
Also Published As
Publication number | Publication date |
---|---|
CN103690393B (en) | 2016-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101678621B1 (en) | Composition comprising spicules for skin care | |
CN104173251B (en) | A kind of bone glue of yak former peptide cleawhite pack and preparation method thereof | |
CN1896268B (en) | Extraction method of activated micromolecular sheept germine from sheep embryo and its use | |
CN103550117A (en) | Beauty and skin care product capable of promoting skin repairation and regeneration as well as preparation method and application thereof | |
CN104958244A (en) | Multipurpose product capable of improving in-vivo and in-vitro metabolism of body skin, whitening skin and resisting ageing | |
CN101791283B (en) | Cosmetic capable of eliminating striae gravidarum and scars | |
CN103550126A (en) | Biological acne-removing and scar-lightening repairing emulsion | |
CN103948525B (en) | Anti-aging active composition for epidermis | |
CN104414914A (en) | Striae gravidarum recovery essence | |
CN104173232A (en) | Method for preparing beautifying fluid capable of promoting skin resistance and repairing small-invasive skin | |
CN103690393B (en) | Skin-whitening anti-wrinkle biological silk mask | |
CN103860449B (en) | A kind of skin care with pregrant abdominal stretch marks-removing effect and preparation method thereof | |
CN105616184A (en) | Hyaluronic acid-polypeptide bonded conjugate mask and preparation method thereof | |
US20150182444A1 (en) | Traditional chinese medicine composition for anti-wrinkle | |
CN108743921A (en) | It is a kind of to prevent the reparation liquid and its preparation method and application that scar is formed | |
CN105560092A (en) | Micro-repairing cream and preparation method thereof | |
CN110368347A (en) | Anti-ageing reparation double-layer bi-color essence of one kind and preparation method thereof | |
JP2023526854A (en) | Skin care products containing a protein matrix | |
CN106349356A (en) | Protein with irisin functional structure and application thereof | |
CN103705394B (en) | Anti-acne disappears the biological silk mask of trace | |
CN102349655A (en) | Collagen polyphenol granules | |
CN104323966A (en) | Golden hydrotherapy composition and using method thereof | |
CN101099720A (en) | Traditional Chinese medicine melon and fruit beautifying face-applying cream and preparing method | |
CN103599054A (en) | Mask containing peanut protein polypeptide and preparation method thereof | |
CN113318004A (en) | Repair essence and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: GUANGDONG LIZI BIOLOGICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: WANG HONGBO Effective date: 20150709 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20150709 Address after: 528300, No. 9, building 1, 1-2 East Avenue, Ronggui Desheng neighborhood committee, Shunde District, Foshan, Guangdong Applicant after: GUANGDONG LIZI BIOLOGICAL TECHNOLOGY CO.,LTD. Address before: Garden Road Shunde District Ronggui street 528303 Silver City Sports in Guangdong province Foshan city 3 Building No. 201 Applicant before: Wang Hongbo |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Whitening anti wrinkle biological Silk Mask Effective date of registration: 20201124 Granted publication date: 20160713 Pledgee: Guangdong Nanhai Rural Commercial Bank branch branch of Limited by Share Ltd. Pledgor: GUANGDONG LIZI BIOLOGICAL TECHNOLOGY Co.,Ltd. Registration number: Y2020980008397 |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160713 |